Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats

Table 1

Serum lipid profile before and after experiments. There were no significant differences between bezafibrate-treated and nontreated groups (𝑃>0.05).

Groups	Total cholesterol (mg/dL)		Triglyceride (mg/dL)		HDL-C (mg/dL)		LDL-C (mg/dL)
	Before	After	Before	After	Before	After	Before	After
Control	66.00±6.79	84.40±8.74	93.16±6.72	73.40±5.88	28.33±4.19	44.66±5.01	25.56±1.94	28.52±3.66
Control + bezafibrate	84.40±8.74	79.80±9.35	63.40±5.88	87.00±6.77	44.66±5.01	33.60±4.24	19.63±2.44	20.76±2.56
Diabetic	70.33±5.44	72.25±7.06	81.80±15.02	71.25±12.37	26.00±3.55	33.40±2.76	19.63±2.44	20.76±2.56
Diabetic + bezafibrate	72.25±7.06	85.42±9.18	71.25±12.37	93.75±10.43	33.40±2.76	37.14±4.74	21.16±2.78	24.20±5.67

Data are expressed as mean ± SE.